Navigation Links
Melior Enters Research Collaboration with AstraZeneca
Date:8/19/2008

Melior Discovery, Inc. announced today that it has signed an agreement with AstraZeneca PLC under which Melior’s in-vivo theraTRACE indications discovery platform will be used to evaluate the therapeutic activity of selected AstraZeneca compounds.

EXTON, Pa. (Business Wire EON) August 19, 2008 -- "Our agreement represents a significant opportunity for Melior to deliver value to AstraZeneca through the application of our unique and innovative in vivo testing platform," said Andrew Reaume, PhD, President and CEO of Melior. "We look forward to a productive collaboration."

Melior Discovery Overview

Melior Discovery is leading the transformation of drug repositioning with its unique theraTRACE platform of multiplexed in vivo models. Melior is using theraTRACE to both build an internal pipeline of development candidates as well as sharing this capability with pharmaceutical and biotechnology company partners. In the former case, Melior identifies and develops "privileged" compounds that have been discontinued by other companies for lack of efficacy in their original indications. Melior is also able to identify appropriate compounds for repositioning by leveraging a close working relationship with the renowned medicinal chemist, Dr. Christopher Lipinski. In its partnered arrangements, Melior offers pharmaceutical partners an approach to expand their late-stage pipelines with safe, high-quality drug candidates

Melior Discovery is located in Exton, PA.

Read the full story at http://www.prweb.com/releases/melior/astrazeneca/prweb1226754.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1

Related biology technology :

1. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
2. American Laser Centers Opens Three Minneapolis-St. Paul Area Clinics
3. Chromos enters into an Arrangement Agreement
4. NeoStem Forges Ahead in Its Plan to Open Adult Stem Cell Collection Centers in Key Locations that Can Serve as Hubs to Service Clients Nationwide
5. A Statement From Larry Corey, MD, of the HIV Vaccine Trials Network Regarding the New HIV Infection Statistics Released Today by the Centers for Disease Control
6. Albemarle Enters Ibuprofen Agreement with Dr. Reddys
7. WorldHeart Enters into a Recapitalization Agreement and Receives Bridge Financing
8. CTI Enters Into Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data for Potential U.S. Supplemental Marketing Application
9. Microchip Biotechnologies, Inc. Enters Into License Arrangement With GE Healthcare for Fundamental Microfluidic Patents
10. Alta Bates Summit Medical Center Opens Two Warm, Supportive Patient Centers: Carol Ann Read Breast Health Center and Family Resource Center
11. CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 Melior Enters Research Collaboration with AstraZeneca 
(Date:4/20/2017)... (PRWEB) , ... April 20, 2017 , ... ... to the scientific and clinical research community’s growing body of knowledge during its ... in the Gracie Theatre and the adjacent Darling Atrium. During the event, undergraduates, ...
(Date:4/20/2017)... MA (PRWEB) , ... April 20, 2017 , ... ... brightness light sources for advanced technology applications, announced today that Chief Executive Officer ... (NAAB). , SEMI is the global industry association connecting the electronics ...
(Date:4/20/2017)... , April 20, 2017 Dutch philosopher Koert van ... ,Next Nature, at the University of Technology in Eindhoven - has written ... this letter, he calls on humanity to avoid becoming a slave and victim ... ... Dutch philosopher Koert van Mensvoort – founder of the ...
(Date:4/19/2017)... ... April 18, 2017 , ... The Vibrating ... key device for generating monodisperse droplets of known diameters for research applications such ... monodisperse solid particles by drying monodisperse droplets. , The VOAG requires forcing ...
Breaking Biology Technology:
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access ... 15.1% over the next decade to reach approximately $1,580 million by ... and forecasts for all the given segments on global as well ...
Breaking Biology News(10 mins):